KCNQ3

gene product
EBN2, Kv7.3
This gene encodes a protein that functions in the regulation of neuronal excitability. The encoded protein forms an M-channel by associating with the products of the related KCNQ2 or KCNQ5 genes, which both encode integral membrane proteins. M-channel currents are inhibited by M1 muscarinic acetylcholine receptors and are activated by retigabine, a novel anti-convulsant drug. Defects in this gene are a cause of benign familial neonatal convulsions type 2 (BFNC2), also known as epilepsy, benign neonatal type 2 (EBN2). Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2014]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Antibodypedia Validation Initiative

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

Antibody

  or   Clear
Enhanced validation
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Validated within AVI
Eligible for validation within AVI
141 antibodies from 20 providers.

Antibody properties

General

Applications

or Cancel
AntibodyRefsTypeWBELICCIPIHCFC
GeneTex
4 antibodies
antibodies-online
52 antibodies
Invitrogen Antibodies
2 antibodies
Novus Biologicals
2 antibodies
LifeSpan BioSciences, Inc.
25 antibodies
Aviva Systems Biology
5 antibodies
Biorbyt
12 antibodies
OriGene
4 antibodies
Abnova Corporation
4 antibodies
Acris Antibodies GmbH
3 antibodies
NovoPro Bioscience Inc.
1 antibody
MyBioSource
3 antibodies
Creative Diagnostics
2 antibodies
Sigma-Aldrich
2 antibodies
GenWay
1 antibody
United States Biological
13 antibodies
Abgent
2 antibodies
ProSci
2 antibodies
Everest Biotech
1 antibody
St John's Laboratory
1 antibody